Search Results - "Hirsch, I. B."

Associations between HbA1c and continuous glucose monitoring‐derived glycaemic variables by Hirsch, I. B., Welsh, J. B., Calhoun, P., Puhr, S., Walker, T. C., Price, D. A.

“…Aims To identify clinically useful associations between HbA1c levels and various continuous glucose monitoring‐derived metrics. Methods We retrospectively…”
Get full text

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study by HOLLANDER, P. A, ELBEIN, S. C, LUCAS, C. P, LODEWICK, P. A, CANOVATCHEL, W, JAIN CHUNG, HAUPTMAN, J, HIRSCH, I. B, KELLEY, D, MCGILL, J, TAYLOR, T, WEISS, S. R, CROCKETT, S. E, KAPLAN, R. A, COMSTOCK, J

“…Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. P A Hollander , S C Elbein , I B Hirsch , D…”
Get full text

Non‐insulin treatments for Type 1 diabetes: critical appraisal of the available evidence and insight into future directions by Wright, L. A., Hirsch, I. B.

“…Intensive insulin therapy is the mainstay of treatment for people with Type 1 diabetes, but hypoglycaemia and weight gain are often limiting factors in…”
Get full text

Self-monitoring of blood glucose by Garg, S K, Hirsch, I B

“…Many would argue that the introduction of modern-day diabetes management started 30 years ago with the introduction of self-monitoring of blood glucose (SMBG)…”
Get full text

Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study by Sillars, B, Davis, W.A, Hirsch, I.B, Davis, T.M.E

“…Aim: To determine whether combination of metformin-sulphonylurea is associated with an increased risk of cardiovascular disease (CVD) and mortality in an urban…”
Get full text

What is innovation in the area of medicines? The example of insulin and diabetes by Beran, D., Hirsch, I. B., Yudkin, J. S.

Get full text

Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI‐liraglutide study 5) by Ahmadi, S. S., Filipsson, K., Dimenäs, H., Isaksson, S. S., Imberg, H., Sjöberg, S., Ahrén, B., Dahlqvist, S., Gustafsson, T., Tuomilehto, J., Hirsch, I. B., Lind, M.

“…Summary Aim Use of the glucagon‐like peptide 1 receptor agonist liraglutide has been shown to reduce weight. Different types of anthropometric measurements can…”
Get full text

Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal–bolus treatment in people with Type 1 diabetes: 1–year results from a randomized clinical trial (BOOST® T1) by Hirsch, I. B., Franek, E., Mersebach, H., Bardtrum, L., Hermansen, K.

“…Aims To evaluate the long‐term safety and efficacy of a simplified basal–bolus regimen of once‐daily insulin degludec/insulin aspart (IDegAsp) with additional…”
Get full text

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial by Lind, Marcus, Polonsky, William, Hirsch, Irl B, Heise, Tim, Bolinder, Jan, Dahlqvist, Sofia, Schwarz, Erik, Ólafsdóttir, Arndís Finna, Frid, Anders, Wedel, Hans, Ahlén, Elsa, Nyström, Thomas, Hellman, Jarl

“…IMPORTANCE: The majority of individuals with type 1 diabetes do not meet recommended glycemic targets. OBJECTIVE: To evaluate the effects of continuous glucose…”
Get full text

Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM by Tsai, E. C., Hirsch, I. B., Brunzell, J. D., Chait, A.

“…Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. E C Tsai , I B Hirsch , J D…”
Get full text

Self-monitoring of blood glucose by Garg, S, Hirsch, I B

“…Studies have shown that reducing A1c levels can delay and/or reduce the overall risk of microvascular and macrovascular complications associated with both type…”
Get full text

Characteristics of adult‐ compared to childhood‐onset type 1 diabetes by Casu, A., Kanapka, L. G., Foster, N. C., Hirsch, I. B., Laffel, L. M., Shah, V. N., DeSalvo, D. J., Lyons, S. K., Vendrame, F., Aleppo, G., Mastrandrea, L. D., Pratley, R. E., Rickels, M. R., Peters, A. L.

“…Aims To compare diagnosis characteristics, diabetes management and comorbidities in a population diagnosed with type 1 diabetes in childhood with those in a…”
Get full text

Associations between HbA 1c and continuous glucose monitoring-derived glycaemic variables by Hirsch, I B, Welsh, J B, Calhoun, P, Puhr, S, Walker, T C, Price, D A

“…To identify clinically useful associations between HbA levels and various continuous glucose monitoring-derived metrics. We retrospectively analysed…”
Get full text

Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST super( registered ) T1) by Hirsch, IB, Franek, E, Mersebach, H, Bardtrum, L, Hermansen, K

“…Aims To evaluate the long-term safety and efficacy of a simplified basal-bolus regimen of once-daily insulin degludec/insulin aspart (IDegAsp) with additional…”
Get full text

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI by Lind, Marcus, Ólafsdóttir, Arndís F., Hirsch, Irl B., Bolinder, Jan, Dahlqvist, Sofia, Pivodic, Aldina, Hellman, Jarl, Wijkman, Magnus, Schwarcz, Erik, Albrektsson, Henrik, Heise, Tim, Polonsky, William

“…OBJECTIVE Continuous glucose monitoring (CGM) reduces HbA1c and time spent in hypoglycemia in people with type 1 diabetes (T1D) treated with multiple daily…”
Get full text

Effect of stepped hypoglycemia on regional cerebral blood flow response to physiological brain activation by Powers, W J, Hirsch, I B, Cryer, P E

“…The effect of vasoactive stimuli on cerebral blood flow (CBF) has been variously reported as normal or impaired by hypoglycemia. We measured regional CBF…”
Get full text

Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial) by Lind, Marcus, Hirsch, Irl B, Tuomilehto, Jaakko, Dahlqvist, Sofia, Ahrén, Bo, Torffvit, Ole, Attvall, Stig, Ekelund, Magnus, Filipsson, Karin, Tengmark, Bengt-Olov, Sjöberg, Stefan, Pehrsson, Nils-Gunnar

“…Study question What are the effects of liraglutide, an incretin based treatment, on glycaemic control in people with type 2 diabetes treated with multiple…”
Get full text

Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients by Espina, C, Jenkins, I, Taylor, L, Farah, R, Cho, E, Epworth, J, Coleman, K, Pinelli, J, Mentzer, S, Jarrett, L, Gooley, T, O'Donnell, P, Hirsch, I B, Bar, M

“…Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative treatment for patients with hematological malignancies. However, is associated…”
Get full text

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5) by Ólafsdóttir, Arndís F., Bolinder, Jan, Heise, Tim, Polonsky, William, Ekelund, Magnus, Wijkman, Magnus, Pivodic, Aldina, Ahlén, Elsa, Schwarcz, Erik, Nyström, Thomas, Hellman, Jarl, Hirsch, Irl B., Lind, Marcus

“…Aim To identify responders to continuous glucose monitoring (CGM) in relation to reductions in HbA1c and percentage of time spent in hypoglycaemia after…”
Get full text

Intensive treatment of type 1 diabetes by Hirsch, I B

“…There have been amazing advances for the treatment of type 1 diabetes. As clinicians proceed into the twenty-first century, it is appropriate to reflect both…”
Get more information